AETHLON MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.36 USD | -9.51% |
|
-6.85% | -37.90% |
| Feb. 14 | Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
| Feb. 14 | Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024 |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Aethlon Medical S...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.
Calendar
2024-06-25
- Q4 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.36
USD
Average target price
25.05
USD
Spread / Average Target
+1,741.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -37.90% | 3.56M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- AEMD Stock
- News Aethlon Medical, Inc.
- Transcript : Aethlon Medical, Inc., Q2 2024 Earnings Call, Nov 14, 2023
